lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Combivir]
RxNorm concept 213088, branded drug (sbd). Prescribable name: COMBIVIR 150 MG / 300 MG Oral Tablet.
- RxCUI
- 213088
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/213088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
3TC 150 MG / AZT 300 MG Oral Tablet [Combivir]; Combivir (lamiVUDine 150 MG / zidovudine 300 MG) Oral Tablet; Combivir (lamivudine 150 MG / zidovudine 300 MG) Oral Tablet; lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [Combivir]
Related concepts
- lamivudine 150 MG (SCDC, consists of)
- zidovudine 300 MG (SCDC, consists of)
- lamivudine 150 MG / zidovudine 300 MG [Combivir] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Combivir (BN, has ingredient)
- lamivudine 150 MG / zidovudine 300 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 49702020218
- 52959054602
- 52959054603
- 52959054604
- 52959054606
- 52959054608
- 52959054610
- 52959054614
- 52959054615
- 52959054620
- 52959054628
- 60760059504
- 60760059514
- 66267050906
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 213088 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/213088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 213088. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.